CMV VIREMIA
Clinical trials for CMV VIREMIA explained in plain language.
Never miss a new study
Get alerted when new CMV VIREMIA trials appear
Sign up with your email to follow new studies for CMV VIREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common virus treatment shrink breast cancer brain tumors?
Disease control Recruiting nowThis study tests whether an anti-CMV drug (valganciclovir) combined with standard care can shrink brain tumors in breast cancer patients whose disease has spread to the brain and who also have a CMV infection. About 28 adults with progressive brain metastases and CMV will receive…
Matched conditions: CMV VIREMIA
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated May 26, 2026 05:33 UTC
-
Heart transplant study tests safer CMV prevention
Prevention Recruiting nowThis study compares two drugs, letermovir and valganciclovir, to see which is safer and more effective at preventing CMV infection in heart transplant patients at moderate to high risk. About 150 adult heart transplant recipients will take one of the drugs for several months. The…
Matched conditions: CMV VIREMIA
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Prevention
Last updated May 26, 2026 05:39 UTC